Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02027532 · ClinicalTrials.gov registry record · NA

Prevention of Infection in Closed Fractures: Cefazolin Versus Vancomycin

A NA study, sponsored by University of Tennessee.

Terminated
Registry status
NA
Development phase
430
Enrollment target

NCT02027532: Clinical Trial NA study, sponsored by University of Tennessee.

NCT02027532 is a NA study that was terminated before completion, run by University of Tennessee. The registered enrollment target is 430 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (69% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02027532, a NA study, was terminated before completion, sponsored by University of Tennessee.

TERMINATED
Registry status
NA
Development phase
430 participants
Enrollment target

Study Summary

The purpose of this study is to compare the incidence rate of infection in surgical patients with closed fractures treated prophylactically with Cefazolin versus Vancomycin in the peri-operative period. The hypothesis of this study is that patients undergoing surgical treatment for closed fractures who are treated prophylactically with Vancomycin will have a lower incidence rate of infection than patients who are treated prophylactically with Cefazolin.

Interventions

  • DRUG Vancomycin
  • DRUG Cefazolin

Trial Details

FieldValue
Enrollment Target 430 participants
Start Date 2009-10
Est. Completion 2017-12
Phase NA
University of Tennessee

96 total trials

Why NCT02027532 stopped before completion

NCT02027532 is an interventional study that assigns participants to a tested intervention. The registered 430 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (69% lower).

The record links to 0 conditions, and to 2 interventions - of which Vancomycin is the first listed.

NCT02027532 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT02027532 about?

NCT02027532 is a clinical study titled "Prevention of Infection in Closed Fractures: Cefazolin Versus Vancomycin". The purpose of this study is to compare the incidence rate of infection in surgical patients with closed fractures treated prophylactically with Cefazolin versus Vancomycin in the peri-operative period. The hypothesis of this study is that patients undergoing surgical treatment for closed fractures...

What is the current status of trial NCT02027532?

This trial is currently terminated. It is a NA study. The enrollment target is 430 participants. The study started on 2009-10. Estimated completion is 2017-12.

What interventions are being tested in trial NCT02027532?

The interventions under investigation include: Vancomycin (DRUG), Cefazolin (DRUG).

Who is sponsoring clinical trial NCT02027532?

This trial is sponsored by University of Tennessee, which has 96 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT02027532's enrollment target sits among peer trials

430 235th of 2000 higher than 1,765 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT05327023 · 430 participants · Phase 1

    Donor Lymphocyte Infusion After Allogeneic Hematopoietic Cell Transplantation for High-Risk Hematologic Malignancies

  • NCT05457985 · 430 participants · NA

    Testing Adaptive Interventions to Improve Posttraumatic Stress Disorder Treatment Outcomes in Federally Qualified Health Centers

  • NCT05532982 · 430 participants

    Parkinson's Disease in Asian Americans

  • NCT05844891 · 430 participants · NA

    Telehealth-Enhanced Asthma Care for Home After the Emergency Room

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT02027532, the US trial registry maintained by the National Library of Medicine. NCT02027532 (mid enrollment · none site footprint · terminated) retrieved and formatted by PlainTrial, see methodology.